← Open Payments lookup

ALINA RAYAMAJHI: Open Payments

NPI 1770254286 · MISSION HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$574 in 17 payments from 12 companies in 2025. Trend: 2023 $1,417 · 2024 $1,988 · 2025 $574

Food & beverage: $574
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation1$74
Otsuka America Pharmaceutical, Inc.3$73
Mallinckrodt Hospital Products Inc.1$70
Ardelyx, Inc.1$67
Amgen Inc.3$67
KYOWA KIRIN, INC.1$50
AstraZeneca Pharmaceuticals LP2$40
GlaxoSmithKline, LLC.1$32
Calliditas Therapeutics US Inc.1$30
Lilly USA, LLC1$28

Products named: JYNARQUE, ACTHAR, XPHOZAH 30 MG, KRYSTEXXA, BENLYSTA, TARPEYO, JARDIANCE, Vafseo.

Industry payments across CA — which companies pay providers there.